Companies / China
Roche Receives Extended Indication For Chemotherapy Drug Xeloda
September 2008 | Product LaunchNews: Swiss pharmaceutical company Roche's oral chemotherapy drug, Xeloda (capecitabine), has been approved by China's State Food and Drug Administration (SFDA) for the treatment of stomach cancer. The drug is already used for treating metastatic breast cancer and metastatic colorectal cancer. Xeloda has shown lower side effects and better effectiveness compared to intravenous chemotherapies during clinical experiments.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
